Sino Pharmaceutical
先通医药
elsewhere's corpus does not genuinely cover "Sino Pharmaceutical" — none of the retrieved material describes this company directly. The only surface matches are name-adjacent: 神州细胞 (688520.SH, Sinocelltech), a Qiming Venture Partners portfolio company that appears in Qiming's roundups, for instance receiving a 2025 Golden Bull listed-company sci-tech innovation award . The rest of the material in this result set is about other companies entirely — LongBio Pharma's June 2026 Hong Kong IPO , Insilico Medicine's listing , Zai Lab's zoci clinical data — and shouldn't be read as facts about Sino Pharmaceutical. If you meant Sinocelltech (神州细胞), elsewhere can only confirm it as a Qiming portfolio company; a fuller profile isn't in the corpus.
AI-generated — may contain errors, please verify.
Coverage
Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Vol. 38, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners Portfolio Companies Make 2025 Beijing Top 100 Private Enterprise Rankings
The list aims to highlight trends in Beijing's private-sector economy and industrial distribution, identify a cohort of high-quality private enterprises that align with the "high-end, precision, and cutting-edge" economic structure and demonstrate leading, exemplary, and driving effects, and encourage and guide private enterprises in practicing new development concepts to promote high-quality growth.
Qiming Venture Partners Weekly | Portfolio Company Updates and Funding News Vol. 21, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Four Portfolio Companies Win 2025 Sci-Tech Innovation Golden Bull Awards
The "Golden Bull Award" is one of the most influential honors in China's capital markets. The Sci-Tech Innovation Golden Bull Award aims to showcase outstanding listed and unlisted companies in strategic emerging industries, while also recognizing the patient capital that diligently supports the rise of new high-tech enterprises.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 16, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Everything Has Two Sides: How Can "Nuclear Radiation" Be Used to Make Anti-Cancer Drugs? | FreeS Report 28
Now is the spring of radiopharmaceuticals.
